PROGRAF 1 mg capsule clinical trials
5 indexed studies · 0 currently recruiting
- AuthorisedTherapeutic use (Phase IV)
Personalized tacrolimus treatment for pediatric kidney transplant recipients by using a dosing algorithm and a once-daily tacrolimus formulation
This study looks at a new way to give children who have had a kidney transplant a medicine called tacrolimus. It uses a special guide to help doctors give the right amount of medicine once a day, aiming to keep blood levels just right.
For: pediatric kidney transplant recipientsNetherlands - AuthorisedTherapeutic confirmatory (Phase III)
REVOLUTION; Randomized controlled trial comparing immediate versus extended release tacrolimus; reducing calcineurin inhibitor related toxicity in lung transplantation patients
This study looks at two different ways to give a medicine called tacrolimus to people who have had a lung transplant. The aim is to see if one way causes fewer side effects, especially problems with kidneys. It compares a standard capsule with a longer-acting tablet.
For: lung transplantationNetherlands - Ongoing, recruitingTherapeutic use (Phase IV)
CALCIGRAN FORTE AND DOSING OF IMMUNOSUPPRESSIVE DRUGS IN KIDNEY TRANSPLANT RECIPIENTS
This study is looking at how a common calcium supplement, Calcigran Forte, affects the levels of medicines taken by people who have had a kidney transplant. We want to make sure these important drugs work as well as they should.
For: Kidney transplantationNorway - Ongoing, recruitingTherapeutic use (Phase IV)
Immunosuppressive drug bioequivalence in kidney transplant recipients – Prograf and CellCept
This study looks at how well different versions of medicines (Prograf and CellCept) used after a kidney transplant are absorbed by the body. It helps make sure new versions work just as well as existing ones to protect your new kidney.
For: Organ transplantationNorway - AuthorisedPhase I and Phase II (Integrated)- Other
IL-1β blockade to prevent Immunothrombosis in recipients of a Pancreatic Organ (ILIPO)
This study is looking at new ways to prevent problems after a pancreas transplant in people with diabetes. It will test if a medicine called Kineret can help stop serious infections and rejections, aiming for better health after the transplant.
For: diabetic patients pancreatic transplantFrance